Found 51 matching trials
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer
PHASE1This clinical trial will be conducted as a single-center, open-label, Phase...
Location
University of Iowa Hospitals and Clinics
Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer
PHASE1The purpose of this study is to identify maximum tolerated dose (MTD), that...
Location
Northwestern University
Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial
PHASE1This phase I/II trial tests the safety, side effects and effectiveness of r...
Location
UCLA / Jonsson Comprehensive Cancer Center
TheraSphere With Durvalumab and Tremelimumab for HCC
PHASE2The objective of the ROWAN clinical study is to assess the efficacy of loca...
Status
Active Not Recruiting
Location
University of California San Diego
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia
NAEvaluate the safety and efficacy of Yttrium-90 (90Y) radioembolization for ...
Location
Northwestern University/Northwestern Memorial Hospital
Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors
PHASE1The purpose of this study is to provide supervised access to treatment with...
Location
Cancer Treatment Centers of America at Southwestern Regional Medical Center
Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease
PHASE1The goal of this clinical research study is to find the highest tolerable d...
Location
Multiple Locations
Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option
NAFewer than 15% of hepatoma patients are suitable candidates for surgical re...
Location
Multiple Locations
Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery
PHASE2RATIONALE: Chemoembolization kills tumor cells by blocking the blood flow t...
Location
Northwestern University, Northwestern Memorial Hospital
Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection
EARLY_PHASE1This early phase I trial studies how well nivolumab and yttrium-90 work in ...
Location
Northwestern University